These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6820204)

  • 41. Transplantation of pancreatic islets.
    Lacy PE; Davie JM
    Annu Rev Immunol; 1984; 2():183-98. PubMed ID: 6443340
    [No Abstract]   [Full Text] [Related]  

  • 42. Long-term culture of non-purified rat islets embedded in hydrogel matrix.
    Tatarkiewicz K; Sitarek E; Sabat M; Orlowski T
    Transplant Proc; 1996 Apr; 28(2):831-2. PubMed ID: 8623422
    [No Abstract]   [Full Text] [Related]  

  • 43. Control of diabetes: comparative immunogenicity and function of fetal pancreas and isolated islets.
    Simeonovic CJ; Agostino M; Lafferty KJ
    Transplant Proc; 1984 Aug; 16(4):1064-5. PubMed ID: 6431668
    [No Abstract]   [Full Text] [Related]  

  • 44. Fine specificity of class I MHC recognition in islet allografts.
    Ferguson D; Kohli N; Munn SR
    Transplant Proc; 1995 Dec; 27(6):3222. PubMed ID: 8539924
    [No Abstract]   [Full Text] [Related]  

  • 45. Modification of immunogenicity in perinatal islets isolated and purified in vitro.
    Hegre OD; Serie J; Hickey G
    Transplant Proc; 1984 Aug; 16(4):1057-8. PubMed ID: 6431666
    [No Abstract]   [Full Text] [Related]  

  • 46. Sensitized Lyt-2+ T cells trigger rejection of grafts expressing class I major histocompatibility complex alloantigens.
    Warren HS; Simeonovic CJ; Dixon JE; Pembrey RG; Lafferty KJ
    Transplant Proc; 1986 Apr; 18(2):310-2. PubMed ID: 3083544
    [No Abstract]   [Full Text] [Related]  

  • 47. Elimination of IA-bearing cells by in vitro isolation and culture of neonatal rat pancreatic islets.
    Meloche M; Ketchum RJ; Serie JR; Sutherland DE; Hegre OD
    Transplantation; 1988 Oct; 46(4):614-6. PubMed ID: 2845614
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
    Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
    Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study on transplantation of the pancreatic islet].
    Hu YF
    Zhonghua Yi Xue Za Zhi; 1984 Mar; 64(3):151-3. PubMed ID: 6432264
    [No Abstract]   [Full Text] [Related]  

  • 50. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
    Coulombe M; Lafferty KJ; Gill RG
    Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
    [No Abstract]   [Full Text] [Related]  

  • 51. Pancreatic islet transplantation using H-2 incompatible multiple donors.
    Gotoh M; Maki T; Porter J; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):957-9. PubMed ID: 3152648
    [No Abstract]   [Full Text] [Related]  

  • 52. [Mechanism of rejection of islet of Langerhans xenografts].
    Bühler L; Deng S; Andereggen E; Bubloz C; Mage R; Mentha G; Morel P
    Swiss Surg; 1995; (4):210-3. PubMed ID: 9156823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonendocrine pancreatic cells determine the immunogenicity of major histocompatibility class II-incompatible islets of Langerhans.
    Hiller WF; Steiniger B; Klempnauer J
    Transplant Proc; 1990 Dec; 22(6):2526-7. PubMed ID: 2264135
    [No Abstract]   [Full Text] [Related]  

  • 54. Tissue immunogenicity: the role of MHC antigen and the lymphocyte costimulator B7-1.
    Coulombe M; Yang H; Guerder S; Flavell RA; Lafferty KJ; Gill RG
    J Immunol; 1996 Dec; 157(11):4790-5. PubMed ID: 8943380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abrogation of mouse pancreatic islet allograft rejection by a four-day culture.
    La Rosa FG
    Transplantation; 1988 Aug; 46(2):330-3. PubMed ID: 3136563
    [No Abstract]   [Full Text] [Related]  

  • 56. Successful single donor islet allotransplantation in the streptozotocin diabetes rat model.
    Jahr H; Hussmann B; Eckhardt T; Bretzel RG
    Cell Transplant; 2002; 11(6):513-8. PubMed ID: 12428740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment.
    Fukuzaki T; Gotoh M; Monden M; Dono K; Wada H; Kita Y; Kanai T; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):975. PubMed ID: 7680173
    [No Abstract]   [Full Text] [Related]  

  • 58. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.
    Desai NM; Bassiri H; Odorico JS; Koller BH; Smithies O; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1993 Feb; 25(1 Pt 2):961-2. PubMed ID: 8442280
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.